Aptevo Therapeutics (APVO) Shares Outstanding (2016 - 2023)
Historic Shares Outstanding for Aptevo Therapeutics (APVO) over the last 8 years, with Q3 2023 value amounting to $328763.0.
- Aptevo Therapeutics' Shares Outstanding fell 9354.18% to $328763.0 in Q3 2023 from the same period last year, while for Sep 2023 it was $328763.0, marking a year-over-year decrease of 9354.18%. This contributed to the annual value of $3971.0 for FY2022, which is 9991.89% down from last year.
- Latest data reveals that Aptevo Therapeutics reported Shares Outstanding of $328763.0 as of Q3 2023, which was down 9354.18% from $171441.0 recorded in Q2 2023.
- In the past 5 years, Aptevo Therapeutics' Shares Outstanding ranged from a high of $5.1 million in Q3 2022 and a low of $3971.0 during Q4 2022
- Over the past 5 years, Aptevo Therapeutics' median Shares Outstanding value was $3.2 million (recorded in 2019), while the average stood at $3.3 million.
- Per our database at Business Quant, Aptevo Therapeutics' Shares Outstanding skyrocketed by 9851.99% in 2019 and then tumbled by 9991.89% in 2022.
- Quarter analysis of 5 years shows Aptevo Therapeutics' Shares Outstanding stood at $3.2 million in 2019, then surged by 36.38% to $4.4 million in 2020, then increased by 11.05% to $4.9 million in 2021, then plummeted by 99.92% to $3971.0 in 2022, then soared by 8179.1% to $328763.0 in 2023.
- Its Shares Outstanding stands at $328763.0 for Q3 2023, versus $171441.0 for Q2 2023 and $164533.0 for Q1 2023.